Triasima Portfolio Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Triasima Portfolio Management's LLY Position: Q2 2026 in Review
Triasima Portfolio Management increased its Eli Lilly (LLY) stake by 58% in Q2 2026, buying an estimated $3.78M and bringing the position to 10,046 shares worth $12M. The position accounts for 1.63% of the portfolio, ranked #11.
Triasima Portfolio Management first reported a position in LLY in Q4 2020 and has held it in 19 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Triasima Portfolio Management held 10,046 shares of Eli Lilly worth $12M as of Q2 2026.
- Triasima Portfolio Management bought 3,695 Eli Lilly shares in Q2 2026, an estimated $3.78M.
- Eli Lilly made up 1.63% of Triasima Portfolio Management's portfolio in Q2 2026, its #11 holding.
- Triasima Portfolio Management first reported a position in Eli Lilly in Q4 2020 and has held it in 19 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Triasima Portfolio Management's 13F filing for Q2 2026, filed 21 Jul 2026.